Search
for
Sort by
Research 961–990 of 1000+
- Drug-induced acne
- Gender aspects in skin diseases
- Virilizing Adrenocortical Oncocytoma in a Child: A Case Report
- Histopathological and Ultrastructural Study of Ectodermal Dysplasia/Skin Fragility Syndrome
- Lymphocytic mediated alopecia: histological classification by pattern analysis
- Gender-Affirming Hormone Therapy for Transgender Men
- Fatty acids and related lipid mediators in the regulation of cutaneous inflammation
- Hypersensitivity Reactions to Anticoagulant Drugs
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Adverse health effects of androgen use
- Interventions for morphea
- Ashy Dermatosis
- Skin manifestations of chronic kidney disease
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Management of hair loss diseases
- Soft Nails After Treatment With Aromatic Retinoids
- An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Ovarian Hilus-Cell Hyperplasia and High Serum Testosterone in a Patient With Postmenopausal Virilization
- Focal and Generalized Alopecia
- Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Post‐traumatic erosive dermatosis of the scalp: A hypergranulated variant
- Testosterone- and Cortisol-Secreting Adrenocortical Oncocytoma: An Unusual Cause of Hirsutism
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Rituximab for Bone Lymphoma